Prg Science & Technology Co., Ltd.

This study aims to see if a drug called Progerinin is safe and can help control bone density loss in adults with Werner Syndrome, a rare genetic disorder that causes rapid aging. Up to five participants will take the drug twice daily for one year. The main goal is to check for si…

This early-stage study is testing a new oral medication called PRG-N-01 for adults with Neurofibromatosis Type II (NF2), a genetic condition that causes non-cancerous tumors along nerves. The main goals are to find the safest and most effective dose and to see if the drug can shr…